BIO - BIO-RAD LABORATORIES, INC.
Close
329.75
-11.430 -3.466%
Share volume: 0
Last Updated: Tue 24 Dec 2024 05:59:58 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
19.80%
PREVIOUS CLOSE
CHG
CHG%
$341.18
-11.43
-3.35%
Fundamental analysis
31%
Profitability
15%
Dept financing
34%
Liquidity
75%
Performance
35%
Performance
5 Days
0.93%
1 Month
-1.65%
3 Months
4.75%
6 Months
17.94%
1 Year
3.05%
2 Year
-19.91%
Key data
Stock price
$329.75
DAY RANGE
$328.38 - $341.18
52 WEEK RANGE
$270.34 - $387.99
52 WEEK CHANGE
$2.60
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
10/24/2024
Company detail
CEO: Norman D. Schwartz
Region: US
Website: bio-rad.com
Employees: 8,200
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: bio-rad.com
Employees: 8,200
IPO year: -
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, sells, and markets a range of reagents, apparatus, and laboratory instruments. The clinical Diagnostics segment offers test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories.
Recent news